BiotechTube
Home/Ocular Therapeutix/Dr. Rabia Gurses-Ozden, MD
DR

Dr. Rabia Gurses-Ozden, MD

Chief Medical Officer

Ocular Therapeutix

Therapeutic Areas

Retinal DiseasesAnterior Segment Diseases

Ocular Therapeutix Pipeline

DrugIndicationPhase
AXPAXLI (OTX-TKI)Wet Age-Related Macular DegenerationNDA Submitted
OTX-CSIChronic Dry Eye DiseasePhase 3
OTX-TICGlaucoma / Ocular HypertensionPhase 1
DEXTENZAPost-Surgical Inflammation/Pain; Allergic ConjunctivitisMarketed

Leadership Team at Ocular Therapeutix

AM
Antony Mattessich
President and Chief Executive Officer
DN
Donald Notman
Chief Financial Officer
DM
Dr. Michael Goldstein, MD, MBA
President, Ophthalmology
JC
John Corbet
Chief Commercial Officer
DP
Dr. Pravin Dugel, MD
Managing Director, President of Ocular Retina
View full Ocular Therapeutix profile